| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9344 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.9351 |
| P-glycoprotein Substrate | Non-substrate | 0.8033 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9458 |
| Non-inhibitor | 0.9855 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8808 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9067 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7932 |
| CYP450 2D6 Substrate | Non-substrate | 0.8793 |
| CYP450 3A4 Substrate | Non-substrate | 0.7523 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6301 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9801 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9552 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6464 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9503 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8545 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9110 |
| Non-inhibitor | 0.9747 |
| AMES Toxicity | Non AMES toxic | 0.9133 |
| Carcinogens | Non-carcinogens | 0.8136 |
| Fish Toxicity | High FHMT | 0.7790 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9663 |
| Honey Bee Toxicity | High HBT | 0.7680 |
| Biodegradation | Ready biodegradable | 0.8515 |
| Acute Oral Toxicity | III | 0.8407 |
| Carcinogenicity (Three-class) | Non-required | 0.6665 |